Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Market sentiment signals for Karyopharm Therapeutics (KPTI): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
10 analysts
Options Flow (P/C)
0.26
More calls — Bullish
Avg Consensus PT
$16
+738.8%
Highest Price Target
$56
+2757.1%
Lowest Price Target
$3
+53.1%
Short Interest
33.5%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Piper Sandler | Edward Tenthoff— | +257.1% | $16 → $7 | Maintained | Overweight |
| Jul 31, 2026 | HC Wainwright & Co. | Robert Burns— | +53.1% | $13 → $3 | Downgrade | Buy→Neutral |